ArticleInternational ophthalmology2018

Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.

Alejandro Rodriguez-Garcia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.